PH24909A - Imidazopyridine derivatives and pharmaceutical compositions - Google Patents

Imidazopyridine derivatives and pharmaceutical compositions

Info

Publication number
PH24909A
PH24909A PH35892A PH35892A PH24909A PH 24909 A PH24909 A PH 24909A PH 35892 A PH35892 A PH 35892A PH 35892 A PH35892 A PH 35892A PH 24909 A PH24909 A PH 24909A
Authority
PH
Philippines
Prior art keywords
pharmaceutical compositions
imidazopyridine derivatives
imidazopyridine
derivatives
pharmaceutical
Prior art date
Application number
PH35892A
Inventor
Isao Yanagisawa
Tokuo Koide
Hisataka Shikama
Keiji Miyata
Mitsuaki Ohta
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Publication of PH24909A publication Critical patent/PH24909A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PH35892A 1986-10-07 1987-10-06 Imidazopyridine derivatives and pharmaceutical compositions PH24909A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23986386 1986-10-07

Publications (1)

Publication Number Publication Date
PH24909A true PH24909A (en) 1990-12-26

Family

ID=17051002

Family Applications (1)

Application Number Title Priority Date Filing Date
PH35892A PH24909A (en) 1986-10-07 1987-10-06 Imidazopyridine derivatives and pharmaceutical compositions

Country Status (10)

Country Link
EP (1) EP0266890A1 (en)
JP (1) JPS63225376A (en)
KR (1) KR880005127A (en)
CN (1) CN87106804A (en)
DK (1) DK522487A (en)
HU (1) HU197572B (en)
IE (1) IE872650L (en)
NZ (1) NZ221996A (en)
PH (1) PH24909A (en)
ZA (1) ZA877530B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014084312A1 (en) * 2012-11-30 2014-06-05 アステラス製薬株式会社 Imidazopyridine compound

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4010797A1 (en) * 1990-04-04 1991-10-10 Hoechst Ag SUBSTITUTED AZOLES, METHOD FOR THE PRODUCTION THEREOF, MEANS CONTAINING THEM AND THE USE THEREOF
FR2687675B1 (en) * 1992-01-31 1997-04-18 Roussel Uclaf NOVEL BICYCLIC PYRIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION, THE NEW INTERMEDIATES OBTAINED, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
UA48122C2 (en) * 1993-10-11 2002-08-15 Бік Гульден Ломберг Хеміше Фабрік Гмбх IMIDAZO [1,2-a] PYRIDINE ALCOXYALKYL CARBAMATES, METHOD OF PREPARATION AND MEDICINAL PRODUCTS BASED ON THEM
CN1046726C (en) * 1994-07-28 1999-11-24 比克·古尔顿·劳姆贝尔格化学公司 Imidazopyridine-pyrrolidone, its preparation method and medicinal use
JPH10505332A (en) * 1994-07-28 1998-05-26 ビイク グルデン ロンベルク ヒェーミッシェ ファブリーク ゲゼルシャフト ミット ベシュレンクテル ハフツング Acylimidazopyridine
JPH10505331A (en) * 1994-07-28 1998-05-26 ビイク グルデン ロンベルク ヒェーミッシェ ファブリーク ゲゼルシャフト ミット ベシュレンクテル ハフツング Benzylimidazopyridine
AU698867B2 (en) * 1995-04-21 1998-11-12 Shinnippon Pharmaceutical Inc. Fused imidazo 1,2-a pyridines
KR100756592B1 (en) * 1999-10-08 2007-09-10 그뤼넨탈 게엠베하 Bicyclic imidazo-3-yl-amine derivatives, preparation method thereof and analgesic agent comprising the same
DE19948434A1 (en) * 1999-10-08 2001-06-07 Gruenenthal Gmbh Substance library containing bicyclic imidazo-5-amines and / or bicyclic imidazo-3-amines
DE19948437A1 (en) * 1999-10-08 2001-06-07 Gruenenthal Gmbh New azino-fused bicyclic imidazolyl-amine compounds, obtained by reacting amide, amine and aldehyde, are alpha-2 adrenergic receptor ligands and analgesics
DE50004817D1 (en) * 1999-10-08 2004-01-29 Gruenenthal Gmbh BICYCLIC IMIDAZO-3-YL-AMINE DERIVATIVES SUBSTITUTED ON THE SIX RING
UA80393C2 (en) 2000-12-07 2007-09-25 Алтана Фарма Аг Pharmaceutical preparation comprising an pde inhibitor dispersed on a matrix
DE10117183A1 (en) * 2001-04-05 2002-10-10 Gruenenthal Gmbh Use of substituted imidazo [1,2-a] pyridine compounds as medicaments
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
EP1682133A1 (en) 2003-11-03 2006-07-26 AstraZeneca AB Imidazo 1,2-a pyridine derivatives for the treatment of silent gastro-esophageal reflux
US7666880B2 (en) 2005-03-21 2010-02-23 S*Bio Pte Ltd. Imidazo[1,2-A]pyridine derivatives: preparation and pharmaceutical applications
AR056187A1 (en) 2005-03-21 2007-09-26 S Bio Pte Ltd IMIDAZO DERIVATIVES [1,2-A) PIRIDINE: PREPARATION, PHARMACEUTICAL COMPOSITIONS AND USE TO PREPARE MEDICATIONS
WO2010032195A1 (en) * 2008-09-16 2010-03-25 Csir Imidazopyridines and imidazopyrimidines as hiv-i reverse transcriptase inhibitors
US9126998B2 (en) 2012-11-05 2015-09-08 Bayer Pharma AG Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
US8778964B2 (en) 2012-11-05 2014-07-15 Bayer Pharma Aktiengesellschaft Hydroxy-substituted imidazo[1,2-a]-pyridinecarboxamides and their use
US8796305B2 (en) 2012-11-05 2014-08-05 Bayer Pharma Aktiengesellschaft Carboxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use
US9624214B2 (en) * 2012-11-05 2017-04-18 Bayer Pharma Aktiengesellschaft Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
US9776997B2 (en) 2013-06-04 2017-10-03 Bayer Pharma Aktiengesellschaft 3-aryl-substituted imidazo[1,2-A]pyridines and their use
CN106459090A (en) 2014-02-19 2017-02-22 拜耳制药股份公司 3-(pyrimidine-2-yl)imidazo[1,2-A]pyridines
WO2015140199A1 (en) 2014-03-21 2015-09-24 Bayer Pharma Aktiengesellschaft Cyano-substituted imidazo[1,2-a]pyridinecarboxamides and their use
WO2015165930A1 (en) 2014-05-02 2015-11-05 Bayer Pharma Aktiengesellschaft Enantiomers of the n-(2-amino-5-fluoro-2-methylpentyl)-8-[(2,6-difluorobenzyl)oxy]-2-methylimidazo[1,2-a]pyridine-3-carboxamide, as well as of the di- and trifluoro derivatives for the treatment of cardiovascular diseases
EP3137465A1 (en) * 2014-05-02 2017-03-08 Bayer Pharma Aktiengesellschaft 6-chlorine-substituted imidazo[1,2-a]pyridine carboxamides and the use thereof as soluble guanylate cyclase stimulators
EP3137464A1 (en) * 2014-05-02 2017-03-08 Bayer Pharma Aktiengesellschaft Imidazo[1,2-a]pyridines as stimulators of soluble guanylate cyclase for treating cardiovascular diseases
WO2016087343A1 (en) 2014-12-02 2016-06-09 Bayer Pharma Aktiengesellschaft Heteroaryl-substituted imidazo[1,2-a]pyridines and their use
WO2018184976A1 (en) 2017-04-05 2018-10-11 Bayer Pharma Aktiengesellschaft Substituted imidazo[1,2-a]pyridinecarboxamides and use of same
CN114380819B (en) * 2020-10-22 2024-08-23 鲁南制药集团股份有限公司 Zolpidem intermediate compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0068378B1 (en) * 1981-06-26 1986-03-05 Schering Corporation Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
GB8305245D0 (en) * 1983-02-25 1983-03-30 Fujisawa Pharmaceutical Co Imidazo-heterocyclic compounds

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014084312A1 (en) * 2012-11-30 2014-06-05 アステラス製薬株式会社 Imidazopyridine compound

Also Published As

Publication number Publication date
HU197572B (en) 1989-04-28
DK522487D0 (en) 1987-10-06
ZA877530B (en) 1988-06-29
JPS63225376A (en) 1988-09-20
EP0266890A1 (en) 1988-05-11
CN87106804A (en) 1988-05-18
KR880005127A (en) 1988-06-28
DK522487A (en) 1988-04-08
NZ221996A (en) 1989-08-29
IE872650L (en) 1988-04-07
HUT45252A (en) 1988-06-28

Similar Documents

Publication Publication Date Title
NZ219274A (en) Indolizine derivatives and pharmaceutical compositions
NZ220880A (en) Di-tert-butyl-phenol derivatives and pharmaceutical compositions
NZ220345A (en) Imidazoquinolinylether derivatives and pharmaceutical compositions containing them
NZ221996A (en) Imidazo-pyridine derivatives and pharmaceutical compositions
NZ216793A (en) Phenethanolaminotetraline derivatives and pharmaceutical compositions
NZ222756A (en) Tetrahydropyridine derivatives and pharmaceutical compositions
NZ217931A (en) Pyridone derivatives and pharmaceutical compositions
NZ220171A (en) Dihydro-benzopyran derivatives and pharmaceutical compositions
NZ220214A (en) 3-aminopyrazole derivatives and pharmaceutical compositions
NZ219320A (en) Thienoimidazole derivatives and pharmaceutical compositions
NZ221284A (en) Dihydropyridine derivatives and pharmaceutical compositions
NZ219624A (en) Indole derivatives and pharmaceutical compositions
NZ221717A (en) Azaindole and indolizine derivatives and pharmaceutical compositions
IL82205A (en) Substituted alkane-sulfonamidophenyl derivatives and pharmaceutical compositions containing them
NZ217078A (en) N-piperidyl-benzamide derivatives and pharmaceutical compositions
NZ216416A (en) Benzazepine derivatives and pharmaceutical compositions
NZ222116A (en) 3-propenylcephem derivatives and pharmaceutical compositions; processes for preparation
NZ222670A (en) Cephalosporin derivatives and pharmaceutical compositions
NZ226738A (en) Ginkgolide derivatives and pharmaceutical compositions
IL85840A0 (en) Imidazopyridine derivatives and compositions containing them
NZ225613A (en) Benzazepin-2-one derivatives and pharmaceutical compositions
NZ216720A (en) Diazinylpiperidine derivatives and pharmaceutical compositions
NZ219250A (en) Purine derivatives and pharmaceutical compositions
NZ216875A (en) 7-oxabicycloheptane derivatives and pharmaceutical compositions
NZ217448A (en) Xanthine derivatives and pharmaceutical compositions